Michele Gambardella*, Antonino Crocamo, Vincenzo Barlotti, Augusto La Penna and Gerarda Pirofalo
Apergillosis in immunocompetent critical patients has increased incidence over the past two decades. Patients at risk include those with systemic steroid therapies and deteriorate pulmonary functions (COPD). Hemoptysis is a devastating complication of pulmonary aspergillosis reported in 28.9% of cases.
HTML PDFShare this article
Journal of Clinical Case Reports received 1295 citations as per Google Scholar report